tiprankstipranks
Trending News
More News >
Sight Sciences (SGHT)
NASDAQ:SGHT
US Market

Sight Sciences (SGHT) Earnings Dates, Call Summary & Reports

Compare
80 Followers

Earnings Data

Report Date
May 01, 2025
TBA Not Confirmed
Period Ending
2025 (Q1)
Consensus EPS Forecast
-0.28
Last Year’s EPS
-0.33
Same Quarter Last Year
Based on 8 Analysts Ratings
---

Earnings Call Summary

Earnings Call Date:Mar 05, 2025
|
% Change Since: -1.65%
|
Next Earnings Date:May 01, 2025
Earnings Call Sentiment|Neutral
The earnings call depicted a mixed outlook. While Sight Sciences achieved revenue growth and significant reductions in cash usage, challenges related to Medicare LCDs, a decline in TearCare revenue, and tariff impacts were notable. Clinical advancements and pipeline developments offer positive future potential. Overall, the sentiment reflects cautious optimism amid current challenges.
Company Guidance
In the Sight Sciences Fourth Quarter 2024 Earnings Conference Call, the company reported a total revenue of $19.1 million for Q4 2024, reflecting a 2% year-over-year increase. The surgical glaucoma segment experienced a 9% revenue growth compared to the same quarter in the prior year, while the dry eye segment saw a decline in revenue to $0.3 million due to fewer SmartLid sales. Gross margin for the quarter was 87%, an improvement from 85% in Q4 2023. The company also achieved a 62% reduction in net cash used for the year. For 2025, Sight Sciences projects a revenue range of $70 million to $75 million and adjusted operating expenses between $105 million and $107 million. The guidance considers the effects of the new Medicare LCD, which prohibits multiple MIGS procedures during cataract surgery, leading to an anticipated industry-wide decline in MIGS device utilization. The company is also preparing for potential tariff impacts on its gross margins due to a 20% tariff on goods from China, although efforts are underway to mitigate these costs. Looking ahead, Sight Sciences aims to secure positive reimbursement coverage for its TearCare product and will continue to invest in its Pseudophakic standalone surgical glaucoma market development and TearCare market access efforts.
Revenue Growth
Sight Sciences reported total revenue of $19.1 million for Q4 2024, marking a 2% increase compared to the same period in the prior year.
Surgical Glaucoma Revenue Increase
Surgical glaucoma revenue grew by 9% in Q4 2024 compared to Q4 2023, driven by a 7% increase in ordering accounts and a 6% increase in account utilization.
Reduction in Net Cash Usage
The company achieved a 62% reduction in net cash used for FY 2024 compared to 2023, reflecting disciplined expense management.
Clinical Data and Advancements
Publication of three-year standalone clinical data for Omni and TearCare budget impact analysis, demonstrating effectiveness and potential cost savings.
Pipeline Development
Introduction of OMNI Edge planned for the first half of 2025, with enhancements in viscoelastic delivery designed to improve safety and efficacy.
---

Sight Sciences (SGHT) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

SGHT Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
May 01, 20252025 (Q1)
-0.28 / -
-0.33
Mar 05, 20252024 (Q4)
-0.20 / -0.23
-0.22-4.55% (-0.01)
Nov 07, 20242024 (Q3)
-0.21 / -0.22
-0.2718.52% (+0.05)
Aug 01, 20242024 (Q2)
-0.30 / -0.25
-0.316.67% (+0.05)
May 02, 20242024 (Q1)
-0.28 / -0.33
-0.355.71% (+0.02)
Mar 07, 20242023 (Q4)
-0.32 / -0.22
-0.3537.14% (+0.13)
Nov 07, 20232023 (Q3)
-0.32 / -0.27
-0.4641.30% (+0.19)
Aug 03, 20232023 (Q2)
-0.34 / -0.30
-0.540.00% (+0.20)
May 04, 20232023 (Q1)
-0.39 / -0.35
-0.4928.57% (+0.14)
Mar 13, 20232022 (Q4)
-0.42 / -0.35
-0.34-2.94% (>-0.01)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---

SGHT Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Mar 05, 2025$2.42$2.49+2.89%
Nov 07, 2024$4.68$4.23-9.62%
Aug 01, 2024$7.42$6.31-14.96%
May 02, 2024$5.61$5.96+6.24%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---

FAQ

When does Sight Sciences (SGHT) report earnings?
Sight Sciences (SGHT) is schdueled to report earning on May 01, 2025, TBA Not Confirmed.
    What is Sight Sciences (SGHT) earnings time?
    Sight Sciences (SGHT) earnings time is at May 01, 2025, TBA Not Confirmed.
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is SGHT EPS forecast?
          SGHT EPS forecast for the fiscal quarter 2025 (Q1) is -0.28.
            ---
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis